PharmaEssentia Completes Patient Enrollment For Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera.
In: Contify Life Science News, 2024-06-25
Zeitungsartikel
Zugriff:
Titel: |
PharmaEssentia Completes Patient Enrollment For Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera.
|
---|---|
Zeitschrift: | Contify Life Science News, 2024-06-25 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|